Literature DB >> 29330272

Spontaneous splenic rupture as a rare complication of G-CSF injection.

Soraya Benguerfi1, Fanny Thepault1, Hervé Lena1,2, Charles Ricordel1,2.   

Abstract

Splenic rupture is an infrequent and underdiagnosed side effect of granylocyte colony-stimulating factor (G-CSF). We report the case of a 54-year-old woman with brain and bone metastasis in a lung adenocarcinoma who was admitted for faintness 28 days after a G-CSF injection. Abdominal CT scan confirmed the diagnosis of splenic rupture. A conservative treatment was chosen using a peritoneal cleansing during laparoscopic surgery. Clinicians should be aware of this rare toxicity as it could be severe, but easily reversible using appropriate surgical treatment. Even if prognosis remains poor for patients with lung cancer, invasive procedures could be considered in this rapidly evolving setting, especially in case of reversible adverse event. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  lung cancer (oncology); unwanted effects / adverse reactions

Mesh:

Substances:

Year:  2018        PMID: 29330272     DOI: 10.1136/bcr-2017-222561

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  3 in total

1.  Neutrophil-Lymphocyte Ratio Is Associated With Occurrence of Febrile Neutropenia in Patients Treated With 5-Fluorouracil and Cisplatin.

Authors:  Satomi Kumazawa; Tomohiro Mizuno; Naoyuki Muramatsu; Masakazu Hatano; Takenao Koseki; Hiroshi Matsuoka; Koichi Suda; Ichiro Uyama; Shigeki Yamada
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

Review 2.  Splenic rupture following lenograstim in post-autologous stem cell transplantation treated with emergency open splenectomy: a case report and literature review.

Authors:  Uros Markovic; Cristina Colarossi; Antonio Iuppa; Paola Scire; Ausilia Gorgone; Federica Galbo; Gabriella Amato; Gaetano Moschetti
Journal:  J Int Med Res       Date:  2022-05       Impact factor: 1.573

3.  Analysis of the Safety of Pegfilgrastim Addition in Bleomycin, Etoposide, and Cisplatin Treatment Patients With Germ Cell Tumors.

Authors:  Ryunosuke Nakagawa; Hiroaki Iwamoto; Tomoyuki Makino; Suguru Kadomoto; Hiroshi Yaegashi; Masashi Iijima; Shohei Kawaguchi; Takahiro Nohara; Kazuyoshi Shigehara; Kouji Izumi; Yoshifumi Kadono; Atsushi Mizokami
Journal:  Front Oncol       Date:  2022-01-07       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.